Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BioSign Flu A+B

K-Number: K182157 · 2018-09-18

Decision Date2018-09-18
Product CodePSZ
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BioSign Flu A+B is a medical device manufactured by Princeton BioMeditech Corp.. It received FDA 510(k) clearance on 2018-09-18 under approval number K182157. The device is classified under product code PSZ. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BioSign Flu A+B?

BioSign Flu A+B is a medical device that received FDA 510(k) clearance on 2018-09-18. It is manufactured by Princeton BioMeditech Corp.. The 510(k) number is K182157.

When was BioSign Flu A+B approved by the FDA?

BioSign Flu A+B received FDA 510(k) clearance on 2018-09-18, under approval number K182157.

What company makes BioSign Flu A+B?

BioSign Flu A+B is manufactured by Princeton BioMeditech Corp..

What is the FDA product code for BioSign Flu A+B?

The FDA product code for BioSign Flu A+B is PSZ.

Other Devices by Princeton BioMeditech Corp.

Related Devices (Code: PSZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.